Loading Events

← Back to Events


December 2020

LET’S TALK ABOUT: THE RIGHT TRACK Increasing Inclusivity in 2021

December 9, 2020, 1:00 pm - 2:00 pm EST

LaunchBio's Let's Talk About series aims to inform, educate, and provide actionable takeaways for increasing diversity, equity, and inclusivity (DE&I) in the life sciences. Let's get your company prepared for 2021! This month we have invited industry experts to share the actions they've taken to make the workplace more inclusive. In this session you will learn: How to start a DE&I program Initiatives that advance Inclusivity Getting employees involved Setting DE&I goals for your company

Read More

February 2021

2021 M2D2 $200K Challenge – Apply Today!

February 19, 2021, 12:00 am - 11:30 pm EST

The 2021 M2D2 $200K Challenge is back and entries are now open until February 19th! You could be among a select group of global early-stage medical device, medtech, and biotech innovators and university spinouts who will pitch their ideas to a high-powered, highly influential panel of investors and advisors this March 24th. On the line: a share of $200,000 worth of in-kind, sponsor-provided resources that can help their ideas go to the next level—or even to market! There’s still time…

Read More

April 2021

Neurology Clinical Trials Are Failing. How Can We Fix Them?

April 15, 2021, 10:00 am - 11:00 am EDT

One billion people worldwide suffer from neurological related disorders with limited therapy options. Over 2000 neurological clinical trials start each year in the US alone. Yet, it is estimated that only 5.9% of Phase I neurology drugs are likely to get FDA approval. Research innovation such as new biomarkers or advanced algorithms often do not get translated into clinical practice, slowing progress. Adding to that, the scale, inefficiency and subjectivity of neurological clinical trials makes them inherently difficult. Neuroimaging analysis…

Read More

May 2021


May 6, 2021, 4:00 pm - 5:00 pm EDT

Jody Thelander of J. Thelander Consulting is back with the latest insights and analysis into compensation for US biotech and life sciences private companies. Drawing on new data from the 2021 Private Company Compensation Survey, our expert panel will share trends in base pay, bonuses, total cash and founder/non-founder equity. This can't-miss session will include practical information for founders on how to navigate legal and financial planning issues pre-exit. There will be time for Q & A about how companies…

Read More

COVID-19 Updates: mass.gov. Contact MLSC staff currently working offsite.